Kenneth Krogulski, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 1,785 shares at $2.69 ($5K) on 2021-10-01, disclosed to the SEC on 2021-11-05.
Scheduled purchase ($5k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.69 | 85 | $229 | 4.7% |
| 2 | $2.87 | 85 | $244 | 5.0% |
| 3 | $2.82 | 85 | $240 | 4.9% |
| 4 | $2.76 | 85 | $235 | 4.8% |
| 5 | $2.76 | 85 | $235 | 4.8% |
| 6 | $2.84 | 85 |
| $241 |
| 5.0% |
| 7 | $2.73 | 85 | $232 | 4.8% |
| 8 | $2.71 | 85 | $230 | 4.7% |
| 9 | $2.71 | 85 | $230 | 4.7% |
| 10 | $2.81 | 85 | $239 | 4.9% |
| 11 | $2.76 | 85 | $235 | 4.8% |
| 12 | $2.75 | 85 | $234 | 4.8% |
| 13 | $2.76 | 85 | $235 | 4.8% |
| 14 | $2.63 | 85 | $224 | 4.6% |
| 15 | $2.65 | 85 | $225 | 4.6% |
| 16 | $2.66 | 85 | $226 | 4.7% |
| 17 | $2.64 | 85 | $224 | 4.6% |
| 18 | $2.64 | 85 | $224 | 4.6% |
| 19 | $2.61 | 85 | $222 | 4.6% |
| 20 | $2.61 | 85 | $222 | 4.6% |
| 21 | $2.72 | 85 | $231 | 4.8% |
| Total | $2.72 avg | 1,785 | $5K | 100% |
| Filing → |
| CPIX | BUY | 2025-07-11 | $5K | — | Filing → |
| CPIX | BUY | 2025-06-06 | $5K | — | Filing → |
| CPIX | BUY | 2025-05-09 | $5K | — | Filing → |